Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Venous Thrombosis  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. "Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology." Arch Intern Med. 2002;162(10):1182-9.
Gregson J, Kaptoge S, Bolton T, et al. "Cardiovascular Risk Factors Associated With Venous Thromboembolism." JAMA Cardiol. 2019;4(2):163-173.
Wattanakit K, Cushman M, Stehman-Breen C, Heckbert SR, Folsom AR. "Chronic kidney disease increases risk for venous thromboembolism." J Am Soc Nephrol. 2008;19(1):135-40.
Tsai AW, Cushman M, Rosamond WD, et al. "Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE)." Am J Med. 2002;113(8):636-42.
F
Folsom AR, Cushman M, Heckbert SR, Ohira T, Rasmussen-Torvik L, Tsai MY. "Factor VII coagulant activity, factor VII -670A/C and -402G/A polymorphisms, and risk of venous thromboembolism." J Thromb Haemost. 2007;5(8):1674-8.
Cushman M, Folsom AR, Wang L, et al. "Fibrin fragment D-dimer and the risk of future venous thrombosis." Blood. 2003;101(4):1243-8.
O
Bell EJ, Agarwal SK, Cushman M, Heckbert SR, Lutsey PL. "Orthostatic Hypotension and Risk of Venous Thromboembolism in 2 Cohort Studies." Am J Hypertens. 2016;29(5):634-40.
P
Folsom AR, Cushman M, Heckbert SR, Rosamond WD, Aleksic N. "Prospective study of fibrinolytic markers and venous thromboembolism." J Clin Epidemiol. 2003;56(6):598-603.
Folsom AR, Cushman M, Rasmussen-Torvik LJ, Heckbert SR, Tsai MY. "Prospective study of polymorphisms of the protein Z-dependent protease inhibitor and risk of venous thromboembolism." Thromb Haemost. 2007;97(3):493-4.
Folsom AR, Tang W, Roetker NS, et al. "Prospective study of sickle cell trait and venous thromboembolism incidence." J Thromb Haemost. 2015;13(1):2-9.
Reich LM, Folsom AR, Key NS, et al. "Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism." J Thromb Haemost. 2006;4(9):1909-13.
Aleksic N, Folsom AR, Cushman M, Heckbert SR, Tsai MY, Wu KK. "Prospective study of the A455V polymorphism in the thrombomodulin gene, plasma thrombomodulin, and incidence of venous thromboembolism: the LITE Study." J Thromb Haemost. 2003;1(1):88-94.
Folsom AR, Cushman M, Tsai MY, et al. "A prospective study of venous thromboembolism in relation to factor V Leiden and related factors." Blood. 2002;99(8):2720-5.
Folsom AR, Aleksic N, Wang L, Cushman M, Wu KK, White RH. "Protein C, antithrombin, and venous thromboembolism incidence: a prospective population-based study." Arterioscler Thromb Vasc Biol. 2002;22(6):1018-22.
T
de Haan HG, A Vlieg vanHylckama, Lotta LA, et al. "Targeted sequencing to identify novel genetic risk factors for deep vein thrombosis: a study of 734 genes." J Thromb Haemost. 2018;16(12):2432-2441.
Zakai NA, Lutsey PL, Folsom AR, Heckbert SR, Cushman M. "Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology." Thromb Haemost. 2010;104(2):207-12.